Based on the available information, it can be expected that a generic version of Entresto may become available soon. According to Drug Patent Watch, Entresto's patent expiration date is in October 2027 [1]. However, there are other factors that can influence the availability of generic versions, such as the approval process by the Food and Drug Administration (FDA) and any exclusivity periods.

The website Drugs.com states that there is currently no generic version of Entresto available on the market as of March 2023 [2]. However, the website BioSpace published an article listing nine drugs that will lose patents or exclusivity clauses by the end of 2023, and Entresto is included in that list [3]. This suggests that a generic version of Entresto could become available in the near future.

It is important to note that even after a patent expires, it can take time for generic versions to become available as manufacturers must still go through the FDA's approval process. Additionally, there may be other factors that could delay the availability of a generic version of Entresto.

In summary, based on the available information, it is expected that a generic version of Entresto may become available soon, but there is no exact timeline for its release.

Sources:

* [1] Drug Patent Watch. (n.d.). Entresto. Retrieved from <https://www.drugpatentwatch.com/p/tradename/ENTRESTO>
* [2] Drugs.com. (2023, March 15). Availability - Generic Entresto. Retrieved from <https://www.drugs.com/availability/generic-entresto.html>
* [3] BioSpace. (2022, December 12). 9 Drugs Losing Patents or Exclusivity Clauses by the End of 2023. Retrieved from <https://www.biospace.com/article/9-drugs-losing-patents-or-exclusivity-clauses-by-the-end-of-2023/>